1. Home
  2. LSBK vs ACET Comparison

LSBK vs ACET Comparison

Compare LSBK & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lake Shore Bancorp Inc.

LSBK

Lake Shore Bancorp Inc.

HOLD

Current Price

$14.87

Market Cap

110.0M

Sector

Finance

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$8.55

Market Cap

71.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSBK
ACET
Founded
1891
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.0M
71.3M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
LSBK
ACET
Price
$14.87
$8.55
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$136.00
AVG Volume (30 Days)
9.2K
201.2K
Earning Date
01-23-2026
11-05-2025
Dividend Yield
2.46%
N/A
EPS Growth
105.28
N/A
EPS
1.21
N/A
Revenue
$27,774,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.16
N/A
Revenue Growth
9.61
N/A
52 Week Low
$11.50
$7.15
52 Week High
$16.95
$17.76

Technical Indicators

Market Signals
Indicator
LSBK
ACET
Relative Strength Index (RSI) 52.11 98.14
Support Level $14.66 $0.47
Resistance Level $14.98 $8.84
Average True Range (ATR) 0.22 0.18
MACD -0.05 0.93
Stochastic Oscillator 27.27 95.58

Price Performance

Historical Comparison
LSBK
ACET

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: